Description
CJC-1295 No DAC (CND5) 5mg
Product Overview
CJC-1295 No DAC (CND5) 5mg is a high-purity synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH) designed for laboratory research. Unlike the DAC (Drug Affinity Complex) version, CJC-1295 No DAC has a shorter duration of activity, making it particularly useful for researchers investigating pulsatile growth hormone signaling and receptor activation in controlled experimental settings.
This peptide is widely studied in endocrinology, peptide pharmacology, and cellular signaling research to better understand the regulation of growth hormone secretion and downstream biological pathways.
This product is intended exclusively for laboratory research purposes and is not for human or veterinary use.
Key Features
- High-purity CJC-1295 No DAC research peptide
- 5mg lyophilized powder per vial
- Short-acting GHRH analog
- Research-grade quality
- Manufactured under strict quality control standards
- Ideal for endocrine and peptide research
- Secure packaging for enhanced product stability
Product Specifications
| Specification | Details |
|---|---|
| Product Name | CJC-1295 No DAC |
| Product Code | CND5 |
| Strength | 5mg |
| Form | Lyophilized Powder |
| Peptide Type | Growth Hormone-Releasing Hormone (GHRH) Analog |
| Purity | High Research Grade |
| Storage | Refrigerate at 2°C–8°C or freeze at -20°C for long-term storage |
| Intended Use | Research Use Only |
Research Applications
CJC-1295 No DAC has been investigated in laboratory studies involving:
- Growth hormone-releasing hormone (GHRH) receptor signaling
- Growth hormone secretion pathways
- Endocrine system regulation
- Pituitary gland research
- Cellular communication and signal transduction
- Metabolic pathway research
- Muscle biology
- Regenerative biology
- Peptide pharmacology
- Hormonal signaling mechanisms
These applications remain the subject of ongoing scientific research and should not be interpreted as evidence of therapeutic or clinical benefit.
Mechanism of Interest
CJC-1295 No DAC is designed to bind to GHRH receptors located on pituitary somatotroph cells. In laboratory models, receptor activation stimulates intracellular signaling pathways associated with the synthesis and release of growth hormone.
Because it does not contain the Drug Affinity Complex (DAC), CJC-1295 No DAC exhibits a shorter biological activity than the DAC-modified version. This characteristic makes it useful for studies examining pulsatile hormone release and the dynamics of receptor activation under controlled experimental conditions.
Quality Assurance
Every batch of CJC-1295 No DAC (CND5) 5mg is manufactured using stringent research-grade standards and undergoes comprehensive quality control testing to help ensure purity, identity, and consistency for laboratory research.
Storage Instructions
To maintain product quality:
- Store refrigerated between 2°C and 8°C before use.
- For long-term storage, freeze at -20°C.
- Protect from heat, moisture, and direct sunlight.
- Avoid repeated freeze-thaw cycles after reconstitution.
- Handle using sterile laboratory techniques.
Important Notice
CJC-1295 No DAC (CND5) 5mg is supplied exclusively for scientific and laboratory research. It is not intended for human consumption, medical treatment, veterinary use, or diagnostic purposes. This product should only be handled by qualified professionals in appropriate research facilities.
Why Choose CJC-1295 No DAC (CND5) 5mg?
- Premium research-grade peptide
- High purity for reliable laboratory results
- Short-acting GHRH analog for controlled experimental studies
- Manufactured under rigorous quality standards
- Carefully packaged to preserve stability and integrity
- Suitable for endocrine, peptide, and cellular signaling research
Frequently Asked Questions
What is CJC-1295 No DAC?
CJC-1295 No DAC is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) developed for research purposes. Unlike the DAC-modified version, it has a shorter duration of activity, making it valuable for studies of pulsatile hormone signaling.
What research areas commonly use CJC-1295 No DAC?
Researchers study CJC-1295 No DAC in laboratory investigations involving growth hormone regulation, pituitary function, endocrine signaling, metabolism, peptide pharmacology, and cellular communication.
What is the difference between CJC-1295 No DAC and CJC-1295 with DAC?
The primary difference is the presence of the Drug Affinity Complex (DAC). CJC-1295 with DAC is engineered for a longer duration of activity, whereas CJC-1295 No DAC has a shorter activity profile, making it suitable for research focused on pulsatile growth hormone signaling.
How should CJC-1295 No DAC be stored?
Store the lyophilized peptide at 2°C–8°C before use. For extended storage, freezing at -20°C is recommended. Use appropriate sterile laboratory procedures when handling and preparing the product.
Is this product intended for therapeutic use?
No. CJC-1295 No DAC (CND5) 5mg is intended strictly for laboratory research and is not approved for human or veterinary use.
